NEW YORK, NY -- June 3, 2015 -- About Small Cap Traders and Four Brief Reports

Small Cap Traders makes the connection between sophisticated investors and high quality micro and small cap companies that are currently undervalued. We are an issuer of reports written by experienced financial analysts and who provide a straight forward assessment of a profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

*Special Profile* - Two Clinical Stage Products Lead the Way in a Promising Pipeline

Actinium Pharmaceuticals, Inc. (NYSE-MKT: ATNM), (“the company”) is a biopharmaceutical company that develops innovative targeted payload immunotherapeutics for the treatment of advanced cancers. The company develops cancer drugs, primarily using its Alpha Particle Immunotherapy Technology (“APIT) platform. This patented technology combines monoclonal antibodies (mAB) for targeting specific types of cells with alpha emitting radioisotopes (actinium-225 and bismuth-213), and specific beta emitting radiopharmaceuticals, to precisely target and kill cancerous cells. The Company’s products are based on patented technology co-developed with Memorial Sloan Kettering Cancer Center (MSKCC).

Company Highlights

  • -Completed secondary offering, resulting in approximately $18.4 million in proceeds.
    -Attained Orphan-Drug Status for Actimab™-A.
    -Announced filing for Investigational New Drug meeting with U.S. FDA to finalize development of Iomab™-B.
    -Prepared for Phase 3 Trial of Iomab™-B and Phase 2 Trial of Actimab™-A by mid-year 2015.
    -Merck a leading drug manufacturer holds a large position in company. (Makin ATNM a Possible Acquisition Target)

For a full analyst report on ATNM that includes a company overview, market and competition breakdown, recent events, outlook, valuation, analyst summary and recommendation can be viewed by using the following link at no cost: http://bit.ly/--ATNM--AnalystReport

Text "SmallCap" to 25827 to receive alerts quicker

4 Four Companies Offering Performance Details:

Sino Agro Food, Inc. (OTCQB: SIAF) is an agriculture technology and natural food holding company with principal operations in the People's Republic of China.

The company has released its first quarter financial results. Read highlights of those financials and a statement by the company CEO in this report: http://bit.ly/_SIAF_AnalystReport

Fannie Mae (OTCQB: FNMA) is a government-sponsored enterprise that was chartered by Congress in 1938 to support liquidity, stability and affordability in the secondary mortgage market, where existing mortgage-related assets are purchased and sold.

In a recent economic forecast FNMA stated that the 2015 economic growth forecast was downgraded, but housing is on a better path. Read the economic highlights in the report you can find at this link: http://bit.ly/_FNMA_AnalystReport

Amarin Corp., PLC (NASDAQ: AMRN) is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health.

The company has won a summary judgement in court against the FDA and issued a thorough update of its performance and operations. You can read about it in the report you will find here: http://bit.ly/_AMRN_AnalystReport

Banro Corp. (NYSE-MKT: BAA) is a Canadian gold mining company focused on production from the Twangiza mine, which began commercial production September 1, 2012, and completion of its second gold mine at Namoya located approximately 200 kilometers south of the Twangiza gold mine.

BAA has announced a preferred share dividend payable soon. Get the details of the dividend and the dates involved in the report offered at this link: http://bit.ly/_BAA_AnalsystReport

Forward-Looking Disclaimer   
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.   

Compliance Procedure   
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and may make mistakes. This report was prepared for informational purposes only.  Affiliated parties involved with producing and issuing this report have not been compensated in any form by the profiled company or any related party.  A full disclaimer can be found by viewing the full analyst report. We do not engage in high frequency trading or hold any positions of profiled company. We have not been compensated in any form for these reports.
For more information and services provided beyond this release please use contact information provided below. If you notice any errors or omissions, please notify us below.

A full disclaimer can be found by viewing the analyst report.

If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at editor@smallcaptraders.com. For any urgent concerns or inquiries please contact us at editor@smallcaptraders.com.

Source: Small Cap Traders
Contact: editor@smallcaptraders.com
                         
 

BAA (AMEX:BAA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more BAA Charts.
BAA (AMEX:BAA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more BAA Charts.